GROW vs SRPT · P/E 244, rev $14.4M vs rev $1.13B
US Global Investors Inc (GROW) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
US Global Investors Inc (GROW) is a asset management company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported GROW revenue for 2026-06-30 was $14.4M. Net income was $3.1M. Revenue was up 32.8% from 2025-06-30 to 2026-06-30. GROW currently screens at market cap $32.3M and trailing P/E 244.0.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
GROW currently screens at market cap $32.3M and trailing P/E 244.0. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the GROW and SRPT stock pages for the full models.
Not investment advice.